| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| JP MORGAN CHASE BANK - BONDS | 553,499 | 550,705 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| JP MORGAN CHASE BANK - PUBLICLY TRADED SECURITIES | 957,119 | 1,060,254 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| JP MORGAN CHASE BANK - OTHER SECURITIES | AT COST | 80,128 | 82,938 |
| AMYLYX PHARMACEUTICALS | AT COST | 40,000 | 40,000 |
| AZTHERAPIES INC. | AT COST | 33,250 | 33,250 |
| COGNITIVE CLARITY | AT COST | 46,000 | 46,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FILING FEES | 250 | 0 | 250 | |
| INVESTMENT MANAGEMENT FEES | 8,741 | 8,741 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES PAID | 781 | 781 | 0 | |
| FEDERAL TAX | 449 | 449 | 0 |